| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| encainide | sodium channel protein type 5 subunit alpha | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Cardiac Arrhythmia[MeSHID:D001145] Atrial Flutter[MeSHID:D001282] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
5.01 | approved,investigational,withdrawn | inhibitor |
| encainide | voltage-gated sodium channel alpha nav1.5 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Cardiac Arrhythmia[MeSHID:D001145] Atrial Flutter[MeSHID:D001282] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
5.01 | withdrawn from market | unknown |
| click here to return to the previous page | ||||||||